<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03708523</url>
  </required_header>
  <id_info>
    <org_study_id>201809035RIND</org_study_id>
    <nct_id>NCT03708523</nct_id>
  </id_info>
  <brief_title>Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy</brief_title>
  <official_title>Next Day Early Morning Growth Hormone as Predictor of Pituitary Function After Transsphenoidal Adenomectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study tried to highlight the predictive value of the morning postoperative cortisol&#xD;
      levels, which can act as the prognosis value of the postoperative pituitary function,&#xD;
      providing future medication advices for improving patients' safety of drugs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transsphenoidal adenomectomy usually accompanied by the failure or recovery of the pituitary&#xD;
      gland, which usually causing further hypopituitarism and hormone recovery. In order to&#xD;
      prevent the potential applications of adrenal cortical malfunction after the surgery, many&#xD;
      medical centers will use glucocorticoid supplements during the perioperative period care.&#xD;
      However, this treatment might expose the normal hypothalamic-pituitary-adrenal (HPA) axis&#xD;
      function patients into potential threats after the treatment of glucocorticoid supplements,&#xD;
      such as bone loss, hypertension, emotional distress, and weight gain. To avoid unnecessary&#xD;
      supply of glucocorticoids, the key question is to monitor the pituitary function. Thus, in&#xD;
      this study we try to predict the morning postoperative cortisol levels, for further&#xD;
      prediction of the postoperative pituitary function. To do so, we will review the&#xD;
      retrospective charts of transsphenoidal adenomectomied patients from January, 2013 to April,&#xD;
      2018 in the NTUH Taipei. Use statistical methods analyzing all sorts of medical reports,&#xD;
      including perioperative hormone thresholds.This study tried to highlight the predictive value&#xD;
      of the morning postoperative cortisol levels, which can act as the prognosis value of the&#xD;
      postoperative pituitary function, providing future medication advices for improving patients'&#xD;
      safety of drugs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">November 1, 2018</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Next Day Early Morning Growth Hormone as Predictor of Pituitary Function After Transsphenoidal Adenomectomy</measure>
    <time_frame>2 days</time_frame>
    <description>To predict the morning postoperative cortisol levels, for further prediction of the postoperative pituitary function.</description>
  </primary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Hypopituitarism</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had been treated with TSA were enrolled.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion:&#xD;
&#xD;
        Patients who had been treated with TSA were enrolled.&#xD;
&#xD;
        Exclusion:&#xD;
&#xD;
          1. Hypopituitarism preoperatively.&#xD;
&#xD;
          2. Acromegaly&#xD;
&#xD;
          3. Multiple operations&#xD;
&#xD;
          4. Incomplete hormone data or loss of follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fon-Yih Tsuang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fon-Yih Tsuang</last_name>
    <phone>0972651142</phone>
    <email>tsuangfy@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei city</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>Fon-Yih Tsuang, MD</last_name>
      <phone>0972651142</phone>
      <email>tsuangfy@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 14, 2018</study_first_submitted>
  <study_first_submitted_qc>October 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2018</study_first_posted>
  <last_update_submitted>October 14, 2018</last_update_submitted>
  <last_update_submitted_qc>October 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypopituitarism,Pituitary function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pituitary Diseases</mesh_term>
    <mesh_term>Hypopituitarism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

